Genç Uluçeçen S, İstemihan Z, Çavuş B, Örmeci Çiftcibaşı A, Kaymakoğlu S, Akyüz F. Is Tofacitinib an Option for Salvage Therapy in Active Acute Severe Ulcerative Colitis?. . 2024 ;3(1):19-20. doi: 10.14744/Jenterocolitis.2024.240566.
Genç Uluçeçen S, İstemihan Z, Çavuş B, Örmeci Çiftcibaşı A, Kaymakoğlu S, Akyüz F. Is Tofacitinib an Option for Salvage Therapy in Active Acute Severe Ulcerative Colitis?. . 2024;3(1):19-20. doi: 10.14744/Jenterocolitis.2024.240566
Genç Uluçeçen, S., İstemihan, Z., Çavuş, B., Örmeci Çiftcibaşı, A., Kaymakoğlu, S., & Akyüz, F. (2024). Is Tofacitinib an Option for Salvage Therapy in Active Acute Severe Ulcerative Colitis?. Journal of Enterocolitis, 3(1), 19-20. https://doi.org/10.14744/Jenterocolitis.2024.240566
Genç Uluçeçen, S., et al. "Is Tofacitinib an Option for Salvage Therapy in Active Acute Severe Ulcerative Colitis?." Journal of Enterocolitis, vol. 3, no. 1, 2024, pp. 19-20. https://doi.org/10.14744/Jenterocolitis.2024.240566.
Genç Uluçeçen, S., et al. 2024. "Is Tofacitinib an Option for Salvage Therapy in Active Acute Severe Ulcerative Colitis?." Journal of Enterocolitis 3, no. 1: 19-20. https://doi.org/10.14744/Jenterocolitis.2024.240566.